The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
350 jobs Number of planned job creations
Announcement Date
13 February 2018
Employment effect (start)
13 February 2018
Foreseen end date
31 December 2021
Description
Medical product manufacturer MSD is to create 350 new jobs in Dublin.
The new positions are in quality, engineering, manufacturing and biochemistry. The products that will be manufactured at the Dublin plant will be biological medicines, particularly in the area of immuno-oncology.
MSD currently employs 1700 across Ireland, having increased its workforce in Ireland by 330 last year.
Sources
13 February 2018: RTE
13 February 2018: Silicon Republic.com
Citation
Eurofound (2018), MSD, Business expansion in Ireland, factsheet number 93254, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/93254.